Premenstrual exacerbation of depressive disorders in a community-based sample in the United States

Psychosomatic Medicine

Volumn 66, Issue 5, 2004, Pages 698-706

  Hartlage, Shirley Ann ^a   Brandenburg, Dana L ^b   Kravitz, Howard M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Depression; Epidemiology; Premenstrual exacerbation; Premenstrual magnification

Indexed keywords

ANTIDEPRESSANT AGENT; ORAL CONTRACEPTIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGING; ARTICLE; COMMUNITY; DEPRESSION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOLLICULAR PHASE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METHODOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; PREVALENCE; PRIORITY JOURNAL; REMISSION; SYMPTOMATOLOGY; UNITED STATES;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; ILLINOIS; MENSTRUATION; MIDDLE AGED; PREMENSTRUAL SYNDROME; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 4944229405     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000138131.92408.b9     Document Type: Article

References (40)

1. Abramowitz ES, Baker AH, Freischer SP. Onset of depressive psychiatric crises and the menstrual cycle. Am J Psychiatry 1982;139:475-8.
2. Mandell AJ, Mandell MP. Suicide and the menstrual cycle. JAMA 1967;200:132-3.
3. Baca-Garcia E, Diaz-Sastre C, Ceverino A, Saiz-Ruiz J, Diaz FJ, de Leon J. Association between the menses and suicide attempts: a replication study. Psychosom Med 2003;65:237-44.
4. MacKinnon PC, MacKinnon IL. Hazards of the menstrual cycle. BMJ 1956;1:555.
5. Woods NF, Mitchell ES, Lentz M. Premenstrual symptoms: delineating symptom clusters. J of Womens Health Gend Based Med 1999;8:1053-62.
6. Backstrom T, Hammarback S. Premenstrual syndrome-psychiatric or gynaecological disorder? Ann Med 1991;23:625-33.
7. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, Ling F, Parry B, Pearlstein T, Rosenbaum J, Rubinow D, Schmidt P, Severino S, Steiner M, Stewart DE, Thys-Jacobs S. Is premenstrual dysphoric disorder a distinct entity? J of Womens Health Gend Based Med 1999;8:663-79.
8. Plouffe LJ, Stewart K, Craft KS, Maddox MS, Rausch JL. Diagnostic and treatment results from a southeastern academic center-based premenstrual syndrome clinic: the first year. Am J Obstet Gynecol 1993;169:295-303.
9. Hartlage S, Gehlert S. Differentiating premenstrual dysphoric disorder from premenstrual exacerbations of other disorders: A methods dilemma. Clinical Psychology: Science and Practice 2001;8:242-53.
10. Post RM, Ballenger JC. Kindling models for the progressive development of psychopathology: Sensitization to electrical, pharmacological, and psychological stimuli. In: van Praag HM, series editor; van Praag HM, Lader MH, Rafaelsen OJ, Sachar EJ, volume editors. Experimental and Clinical Psychiatry. New York: Marcel Dekker; 1981;1(4):609-51.
11. Breaux C, Hartlage S, Gehlert S. Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination. J Psychosom Obstet Gynaecol 2000;21:17-24.
12. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001;158:582-6.
13. van den Akker OB, Eves FF, Stein GS, Murry RM. Genetic and environmental factors in premenstrual symptom reporting and its relationship to depression and a general neuroticism trait. J Psychosom Res 1995;39:477-87.
14. Treloar SA, Heath AC, Martin NG. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002;32:25-38.
15. Kendler KS, Silberg JL, Neale MC, et al. Genetic and enviromental factors in aetiology of menstrual, premenstrual, and neurotic symptoms: a population-based twin study. Psychol Med 1992;22:85-100.
16. First MB, Spitzer RL, Gibbon M, Williams JBW (1996, February): Structured Clinical Interview for DSM-IV Axis I Disorders - Non-patient Edition (SCID-I/NP, Version 2.0). (Available from the Biometrics Research Department, New York State Psychiatric Institute, 722 West 168th Street, New York, NY 10032)
17. Orvaschel H (1995, January): Schedule for Affective Disorder and Schizophrenia for School-Age Children Epidemiologic Version-5 Kiddie-SADS-E (K-SADS-E). (Available from Dr. Helen Orvaschel, Nova Southeastern University, Center for Psychological Studies, 3301 College Avenue, Ft. Lauderdale FL 33314)
18. Pai MP, Paloucek FP. The origin of the "ideal" body weight equations. Ann Pharmacother 2000;34:1066-9.
19. Warner P, Bancroft J. Factors related to self-reporting of the premenstrual syndrome. Br J Psychiatry 1990;157:249-60.
20. Marvan ML, Escobedo C. Premenstrual symptomatology: role of prior knowledge about premenstrual syndrome. Psychosom Med 1999;61:163-7.
21. Kish L. Survey sampling. New York: Wiley & Sons; 1965.
22. Ekholm UB, Ekholm NO, Backstrom T. Premenstrual syndrome: comparison between different methods to diagnose cyclicity using daily symptom ratings. Acta Obstet Gynecol Scand 1998;77:551-7.
23. Schnurr PP. Measuring amount of symptom change in the diagnosis of premenstrual syndrome: psychological assessment. J Consult Clin Psychol 1989;1:277-83.
24. Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope HG, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM-III-R (SCID): multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-6.
25. Segal DL, Hersen M, Van Hasselt VB. Reliability of the Structured Clinical Interview for DSM-III-R: an evaluative review. Compr Psychiatry 1994;35:316-27.
26. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch Gen Psychiatry 1978;35:773-82.
27. Orvaschel H, Beeferman D, Kabacoff R. Depression, self-esteem, sex, and age in a child and adolescent clinical sample. J Clin Child Psychology 1997;26:285-89.
28. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons.
29. Weber EU, Bockenholt U, Hilton DJ, Wallace B. Determinants of diagnostic hypothesis generation: effects of information, base rates, and experience. J Exp Psychol Learn Mem Cogn 1993;19:1151-64.
30. Parry BL, LeVeau B, Mostofi N, Naham HC, Loving R, Clopton P, Gillin JC. Temperature circadian rhythms during the menstrual cycle and sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects. J Biol Rhythms 1997;12:34-46.
31. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer P. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28.
32. Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 2002;100:435-44.
33. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 1999;56:932-9.
34. Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol 2002;100:1219-29.
35. Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Drugs 2002;62:1869-85.
36. Glick R, Harrison W, Endicott J, McGrath P, Quitkin FM. Treatment of premenstrual dysphoric symptoms in depressed women. J Am Med Womens Assoc 1991;46:182-5.
37. Yonkers KA, White K. Premenstrual exacerbation of depression: one process or two? J Clin Psychol 1992;53:289-92.
38. Jensvold MF. Psychological aspects of women's health care: the interface between psychiatry and obstetrics and gynecology. In: Stewart DE, Stotland NL, editors. Psychological aspects of women's health care: the interface between psychiatry and obstetrics and gynecology. Washington, D.C.: American Psychiatric Press; 1993. p. 165-92.
39. Miller MN, Miller BE, Chinouth R, Coyle BR, Brown GR. Increased premenstrual dosing of nefazodone relieves premenstrual magnification of depression. Depress Anxiety 2002;15:48-51.
40. Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997;33:303-9.